Atsena Advances XLRS Gene Therapy
June 30, 2026
Atsena Therapeutics dose first patient in pivotal XLRS gene therapy trial
2 min read
False
Advertisement
June
New Immune Target in Dry Eye
June 30, 2026
Investigators say rexinoid therapy may represent a new class of dry eye treatment focused on regenerative immune signaling
2 min read
The Fellow Eye Is Never Just a Bystander
June 29, 2026
What does the “fellow eye effect” reveal about ophthalmology’s pre-existing notions of unilateral eye disease?
3 min read
Haag-Streit Announces Appointment of New CCO
June 29, 2026
Anette Chauhan will lead the company’s global commercial activities and organization
1 min read
Standardizing AI for Dry Eye
June 29, 2026
Expert consensus aims to set professional standards for the use of AI in dry eye diagnosis, monitoring, and personalized treatment
2 min read
AI: From Hype to Real-World Clinical Value
June 26, 2026
Examining ophthalmic AI through the lens of clinical value rather than technical novelty
8 min read
Winning the Cataract Battle Before the OR
June 26, 2026
How the Heidelberg Engineering Ecosystem is tackling inefficiencies in traditional cataract workflows.
7 min read
Ocular Surface Control: A Modern Approach to Peri-operative Dry Eye Management
June 26, 2026
Why ocular surface optimization is essential in cataract and refractive surgery
5 min read
Photosynthesis Comes to the Cornea
June 26, 2026
Researchers engineer spinach-derived photosynthetic nanostructures to fight eye inflammation and ocular disease
3 min read
New CEO for Optos
June 26, 2026
Optos appoints Alexandre Montague as Chief Executive Officer
1 min read
Browse by Subspecialties
False
Advertisement